398 related articles for article (PubMed ID: 10559880)
21. Roxithromycin inhibits tumor necrosis factor-alpha-induced matrix metalloproteinase-1 expression through regulating mitogen-activated protein kinase phosphorylation and Ets-1 expression.
Oyama T; Matsushita K; Sakuta T; Tokuda M; Tatsuyama S; Nagaoka S; Torii M
J Periodontal Res; 2007 Feb; 42(1):53-61. PubMed ID: 17214640
[TBL] [Abstract][Full Text] [Related]
22. Common and distinct signalling cascades in the production of tumour necrosis factor-alpha and interleukin-13 induced by lipopolysaccharide in RBL-2H3 cells.
Gon Y; Nunomura S; Ra C
Clin Exp Allergy; 2005 May; 35(5):635-42. PubMed ID: 15898987
[TBL] [Abstract][Full Text] [Related]
23. MK2 targets AU-rich elements and regulates biosynthesis of tumor necrosis factor and interleukin-6 independently at different post-transcriptional levels.
Neininger A; Kontoyiannis D; Kotlyarov A; Winzen R; Eckert R; Volk HD; Holtmann H; Kollias G; Gaestel M
J Biol Chem; 2002 Feb; 277(5):3065-8. PubMed ID: 11741878
[TBL] [Abstract][Full Text] [Related]
24. Hypoxia modulates lipopolysaccharide induced TNF-alpha expression in murine macrophages.
Liu FQ; Liu Y; Lui VC; Lamb JR; Tam PK; Chen Y
Exp Cell Res; 2008 Apr; 314(6):1327-36. PubMed ID: 18255061
[TBL] [Abstract][Full Text] [Related]
25. Endoplasmic reticulum-associated ubiquitin-conjugating enzyme Ube2j1 is a novel substrate of MK2 (MAPKAP kinase-2) involved in MK2-mediated TNFα production.
Menon MB; Tiedje C; Lafera J; Ronkina N; Konen T; Kotlyarov A; Gaestel M
Biochem J; 2013 Dec; 456(2):163-72. PubMed ID: 24020373
[TBL] [Abstract][Full Text] [Related]
26. p38
Menon MB; Gropengießer J; Fischer J; Novikova L; Deuretzbacher A; Lafera J; Schimmeck H; Czymmeck N; Ronkina N; Kotlyarov A; Aepfelbacher M; Gaestel M; Ruckdeschel K
Nat Cell Biol; 2017 Oct; 19(10):1248-1259. PubMed ID: 28920954
[TBL] [Abstract][Full Text] [Related]
27. The mitogen-activated protein kinase (MAPK)-activated protein kinases MK2 and MK3 cooperate in stimulation of tumor necrosis factor biosynthesis and stabilization of p38 MAPK.
Ronkina N; Kotlyarov A; Dittrich-Breiholz O; Kracht M; Hitti E; Milarski K; Askew R; Marusic S; Lin LL; Gaestel M; Telliez JB
Mol Cell Biol; 2007 Jan; 27(1):170-81. PubMed ID: 17030606
[TBL] [Abstract][Full Text] [Related]
28. MAPKAP kinases MK2 and MK3 in inflammation: complex regulation of TNF biosynthesis via expression and phosphorylation of tristetraprolin.
Ronkina N; Menon MB; Schwermann J; Tiedje C; Hitti E; Kotlyarov A; Gaestel M
Biochem Pharmacol; 2010 Dec; 80(12):1915-20. PubMed ID: 20599781
[TBL] [Abstract][Full Text] [Related]
29. MAPKAP kinase 2-deficient mice are resistant to collagen-induced arthritis.
Hegen M; Gaestel M; Nickerson-Nutter CL; Lin LL; Telliez JB
J Immunol; 2006 Aug; 177(3):1913-7. PubMed ID: 16849504
[TBL] [Abstract][Full Text] [Related]
30. Mitogen-activated protein kinase-activated protein kinase 2-deficient mice show increased susceptibility to Listeria monocytogenes infection.
Lehner MD; Schwoebel F; Kotlyarov A; Leist M; Gaestel M; Hartung T
J Immunol; 2002 May; 168(9):4667-73. PubMed ID: 11971016
[TBL] [Abstract][Full Text] [Related]
31. The role of mitogen-activated protein kinase-activated protein kinase 2 in the p38/TNF-alpha pathway of systemic and cutaneous inflammation.
Schottelius AJ; Zügel U; Döcke WD; Zollner TM; Röse L; Mengel A; Buchmann B; Becker A; Grütz G; Naundorf S; Friedrich A; Gaestel M; Asadullah K
J Invest Dermatol; 2010 Feb; 130(2):481-91. PubMed ID: 19657354
[TBL] [Abstract][Full Text] [Related]
32. Reduced oxazolone-induced skin inflammation in MAPKAP kinase 2 knockout mice.
Funding AT; Johansen C; Gaestel M; Bibby BM; Lilleholt LL; Kragballe K; Iversen L
J Invest Dermatol; 2009 Apr; 129(4):891-8. PubMed ID: 18987672
[TBL] [Abstract][Full Text] [Related]
33. Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability.
Mahtani KR; Brook M; Dean JL; Sully G; Saklatvala J; Clark AR
Mol Cell Biol; 2001 Oct; 21(19):6461-9. PubMed ID: 11533235
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of SAPK2a/p38 prevents hnRNP A0 phosphorylation by MAPKAP-K2 and its interaction with cytokine mRNAs.
Rousseau S; Morrice N; Peggie M; Campbell DG; Gaestel M; Cohen P
EMBO J; 2002 Dec; 21(23):6505-14. PubMed ID: 12456657
[TBL] [Abstract][Full Text] [Related]
35. Is MK2 (mitogen-activated protein kinase-activated protein kinase 2) the key for understanding post-transcriptional regulation of gene expression?
Kotlyarov A; Gaestel M
Biochem Soc Trans; 2002 Nov; 30(Pt 6):959-63. PubMed ID: 12440954
[TBL] [Abstract][Full Text] [Related]
36. Distinct functions of the mitogen-activated protein kinase-activated protein (MAPKAP) kinases MK2 and MK3: MK2 mediates lipopolysaccharide-induced signal transducers and activators of transcription 3 (STAT3) activation by preventing negative regulatory effects of MK3.
Ehlting C; Ronkina N; Böhmer O; Albrecht U; Bode KA; Lang KS; Kotlyarov A; Radzioch D; Gaestel M; Häussinger D; Bode JG
J Biol Chem; 2011 Jul; 286(27):24113-24. PubMed ID: 21586572
[TBL] [Abstract][Full Text] [Related]
37. Protein expression of TNF-alpha in psoriatic skin is regulated at a posttranscriptional level by MAPK-activated protein kinase 2.
Johansen C; Funding AT; Otkjaer K; Kragballe K; Jensen UB; Madsen M; Binderup L; Skak-Nielsen T; Fjording MS; Iversen L
J Immunol; 2006 Feb; 176(3):1431-8. PubMed ID: 16424170
[TBL] [Abstract][Full Text] [Related]
38. Distinct cellular functions of MK2.
Kotlyarov A; Yannoni Y; Fritz S; Laass K; Telliez JB; Pitman D; Lin LL; Gaestel M
Mol Cell Biol; 2002 Jul; 22(13):4827-35. PubMed ID: 12052889
[TBL] [Abstract][Full Text] [Related]
39. Mitogen-activated protein kinase-activated protein (MAPKAP) kinase 2 deficiency protects brain from ischemic injury in mice.
Wang X; Xu L; Wang H; Young PR; Gaestel M; Feuerstein GZ
J Biol Chem; 2002 Nov; 277(46):43968-72. PubMed ID: 12215446
[TBL] [Abstract][Full Text] [Related]
40. Low-molecular-weight MK2 inhibitors: a tough nut to crack!
Schlapbach A; Huppertz C
Future Med Chem; 2009 Oct; 1(7):1243-57. PubMed ID: 21426101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
